Skip to main content
Clinical Trials/ISRCTN25258560
ISRCTN25258560CompletedNot Applicable

Multicentre trial of continuous Positive Airway Pressure for chronic therapy of heart failure

niversity Health Network (Toronto) (Canada)0 sites408 target enrollmentStarted: June 17, 2005Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
408

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Male and females between the age of 18 and 79 with history of at least one clinical episode of CHF due to ischaemic heart failure
  • 2. Left ventricular (LV) systolic dysfunction as evidenced by a left ventricular ejection fraction (LVEF) at rest determined by equilibrium radionuclide angiography of less than 40% while on optimal drug therapy at the time of recruitment
  • 3. New York Heart Association (NYHA) functional class two to four
  • 4. Stable condition and stable optimal cardiac medications for at least one month prior to entry
  • 5. Presence of central sleep apnoea defined as more than or equal to 15 apnoeas and hypopneas per hour of sleep of which more than 50% must be central in nature
  • 6. Written informed consent

Exclusion Criteria

  • 1. History of unstable angina, cardiac surgery and/or documented myocardial infarction less than three months prior to entry into the study
  • 2. Acceptance for cardiac transplantation
  • 3. Sleep apnea which is predominantly (i.e. more than or equal to 50%) obstructive in nature
  • 4. Concurrent disease that would markedly limit life expectancy (e.g. lung cancer)
  • 5. Pregnancy

Investigators

Sponsor
niversity Health Network (Toronto) (Canada)

Similar Trials